StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Jaffray Raises Price Target on Johnson & Johnson (JNJ) Following 1Q Report
April 20, 2016 7:42 AM
Piper Jaffray reiterated a Neutral rating on Johnson & Johnson (NYSE: JNJ), and raised the price target to $106.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Notable 52-Week Highs and Lows 4/19: (HL) (JNJ) (TTS) High; (SSE) (CLMT) (TTHI) Low
April 19, 2016 3:30 PM
J&J shares hit new high on strong drug sales, weaker dollar
April 19, 2016 7:02 AM
Johnson & Johnson (JNJ) Tops Q1 EPS by 2c; Updates FY16 Outlook
April 19, 2016 6:41 AM
Johnson & Johnson Reports 2016 First-Quarter Results:
April 19, 2016 6:40 AM
Notable 52-Week Highs and Lows 4/18: (CPXX) (HAS) (JNJ) High; (CLMT) (CHMA) (TTHI) Low
April 18, 2016 3:27 PM
Trading Radar for 4/19: J&J (JNJ), Yahoo!(YHOO), Philip Morris (PM), UnitedHealth (UNH), Discover Financial (DFS) Report
April 18, 2016 2:10 PM
Parents May Know Best, But Admit They Could Use Help When It Comes To Recycling
April 18, 2016 8:31 AM
New Data from U.S. Post-Approval Study Assess Ischemic Stroke and Intracranial Hemorrhage Rates in People with Non-Valvular Atrial Fibrillation Comparing Both Rivaroxaban with Warfarin and Apixaban wi
April 18, 2016 6:00 AM
